Skip to main content
snıff

Boxer

Boxer
Photo: Mood210 / CC BY-SA 3.0 · Wikimedia

192 Boxers in the atlas. Every number on this page has a source.

Population-genetic snapshot of Boxers in the Sniff Atlas, source-graded Mendelian carrier frequencies from Donner 2023, and nutrition guidance tied to the genetic findings above.

Also known as Deutscher Boxer and German Boxer.

See in the atlas → From CanVAS
The plain version

Boxers come from a fairly close-knit family line, meaning their genetic background is somewhat limited compared to some other breeds. They are medium to large dogs, usually weighing around 63 lb, and typically live about 10 years. Boxers share some traits with breeds like the French Bulldog and Bulldog. One health note is that their gene pool includes a condition called Degenerative Myelopathy, so it’s a good idea to talk with your vet or consider genetic testing to keep your dog healthy.

What the atlas says about Boxer

In the atlas, the Boxer clusters consistently as Boxer (100% of the 192 dogs here). At the trait loci, KRT71 runs lower than average (36% here vs 91%); SMOC2 runs lower than average (22% here vs 75%).

Ranks 15 of 107 on the bottleneck severity scale, well into the upper quartile of population contraction. High breed predictability score (4.38), individual dogs of this breed reliably cluster together genetically.

Median lifespan is 10.15 years, about 1.5 years shorter than a typical dog of 28.5 kg, one of the larger gaps in the atlas.

Genetic dimensions · CanVAS atlas

What the genome says about Boxer

Computed from the 18,477 research dogs in the Atlas.

Dogs in the Atlas
192Founders
152 from Hayward2016, 15 from Momozawa, 14 from Shannon
Genetic diversity
0.25Tight
Mean heterozygosity across the breed. Ranks 15th most genetically tight of 107 ranked breeds.
What does genetic diversity mean?

How varied a breed's gene pool is — the share of gene spots where a typical dog of the breed carries two different versions rather than two identical ones.

How to read it: Higher = more diverse. Among well-sampled breeds it ranges roughly 0.22 (least diverse) to 0.33 (most diverse).

Diversity is a strength, not a verdict on any individual dog. Lower diversity means it's worth paying attention to recessive-risk testing — not that a dog is doomed.

Cluster structure
Splits into two genetic sub-populations
Intra-breed RMS distance: 23.06 · likely working/show-line, regional, or kennel lineage split.
What does within-breed variation mean?

How much individual dogs within the breed differ from each other genetically.

How to read it: Higher = more internal variety among individuals of the breed.

Sensitive to how many dogs of the breed we've sampled.

Related breeds
Built from
Distant kin · one shared founding ancestor
In the Working group
Explore the full lineage map →
VBO foundation stock (breeding records) · AKC breed group
Relatedness is documented lineage + kennel family. Genetic-ancestry distance measures diversity, not kinship, so it isn't used here.
How long they live
11.3years (life expectancy)
95% CI 11.3–11.5 · VetCompass, McMillan 2024, n=11,294. source
What does typical lifespan mean?

The median age dogs of the breed tend to reach.

How to read it: Higher = longer-lived. Compare to longevity-for-size to see whether it's just a size effect.

Drawn from population lifespan records; individual dogs vary widely with care, genetics, and luck.

Trait genetics
Allele frequencies at named morphology loci

Frequency of the alternate allele in this breed at each locus's representative SNP.

Body size
IGF13%
HMGA289%
SMAD291%
LCORL40%
STC2100%
ADAMTS1762%
Leg length
FGF4·CFA18100%
FGF4·CFA12100%
Coat
RSPO228%
FGF566%
KRT7137%
MC1R82%
Ear set
MSRB3100%
Skull shape
BMP339%
SMOC222%
n = 192 dogs · high confidence · CanVAS (Brundage 2026) · Sniff Atlas
Names & origins

Other names

The Boxer is also recorded as Deutscher Boxer and German Boxer.

Identified as Boxer (VBO:0200210) in the Vertebrate Breed Ontology (Mullen et al. 2025, CC-BY 4.0) · registry IDs FCI 144 · iDog 48 · VeNom 13724.

Temperament

What Boxers tend toward

Tendencies from owner surveys of purebred Boxers — a leaning across the breed, not a prediction for any one dog. A bar’s strength shows how much of that behavior breed actually explains: for most it’s faint, because the rest is your dog, their training, and the life you give them.

Proximity Seekingbreed ~13%
affectionatealoof
Dog Sociabilitybreed ~8%
less sociablehighly sociable
Biddabilitybreed ~18%
biddableindependent
Agonistic Thresholdbreed ~9%
assertivediffident
Toy-directed Motor Patternsbreed ~18%
toy-directednot toy-directed
Arousal Levelbreed ~8%
arousedcomposed
Human Sociabilitybreed ~11%
less sociablehighly sociable
Environmental Engagementbreed ~9%
high engagementlow engagement
n = 43 dogs · Morrill et al. 2022, Science, Darwin's Ark (CC0)
Owner-reported purebreds; each factor n ≥ 25. "Breed ~%" is the share of this behavior explained by breed.
What you see when you look at a Boxer

What does the genome say about how a Boxer looks?

Boxers look the way they do because of a small set of fixed and near-fixed morphology genes that, taken together, define the visible breed. Each translation below pairs the gene with the trait an owner actually sees, the breed's allele frequency at that locus, and a one-clause causal phrase.

Where the breed-defining genes act, mapped on a generic dog-body key — and how fixed each marker is in the Boxer. The figure is the most-settled marker we read in that region; the full per-locus panel is below. (The silhouette is a shared anatomical guide, not this breed's outline.)

Body sizeSTC2 · 100%Skull shapeBMP3 · 39%EarsMSRB3 · 100%Leg lengthFGF4 CFA12 · 100%Coat & colorMC1R · 82%
CanVAS trait-locus panel (Brundage 2026)
15 morphology markers read across 5 regions. Allele frequency = how fixed a marker is in this breed, not whether your dog carries it.

Size and build

IGF1 is at 3% for the small-body allele, leaving the breed firmly in the larger end of the dog body-size spectrum.

IGF1what this gene does

IGF1 is a gene that plays a key role in determining a dog's body size. It influences how much a dog grows, affecting overall stature.

For your dog: Knowing about IGF1 gives you insight into your dog's size traits, but it’s just one part of the bigger picture when it comes to their health and care.

Full IGF1 gene page →

HMGA2 is near-fixed at 89%, reinforcing the breed's size signal through a second locus on chromosome 10.

HMGA2what this gene does

HMGA2 is a gene that influences body size in dogs, helping determine how big or small a dog grows.

For your dog: Knowing about HMGA2 helps you appreciate the genetic factors behind your dog's size, but it doesn't signal any health issues.

Full HMGA2 gene page →

SMAD2 is near-fixed at 91%, a chromosome-7 height locus differentiating small from giant breeds.

SMAD2what this gene does

SMAD2 is a gene involved in regulating body size by influencing how cells grow and develop.

For your dog: Knowing about SMAD2 helps understand your dog's size traits but isn't linked to health issues; no immediate action needed.

Full SMAD2 gene page →

LCORL sits at 40% at the NCAPG/LCORL height locus on chromosome 3.

LCORLwhat this gene does

LCORL is a gene that influences body size in dogs. It helps determine how big or small a dog might grow.

For your dog: Knowing about LCORL helps you appreciate the genetic factors behind your dog's size, but it’s just one piece of the bigger picture when it comes to health and care.

Full LCORL gene page →

STC2 is near-fixed at 100%, modulating growth-axis signaling toward the breed's body-size set point.

ADAMTS17 sits at 62%. ADAMTS17 is a body-size locus also linked to lens disorders.

ADAMTS17what this gene does

ADAMTS17 is a gene that influences body size and also plays a role in certain eye conditions. It affects the structure of tissues in the eye and elsewhere in the body.

For your dog: If your dog belongs to a breed known to carry ADAMTS17 variants, it’s worth discussing genetic testing and eye exams with your vet to stay ahead of potential issues.

Full ADAMTS17 gene page →

Leg length

The FGF4 retrogene on chromosome 18 is near-fixed in this breed at 100%. This is the leg-length variant. The breed is fully committed to the long-legged form rather than the short-legged Corgi-and-Dachshund body plan.

The FGF4 retrogene on chromosome 12 is near-fixed at 100%, the chondrodystrophic variant associated with intervertebral disc disease risk in breeds that carry it.

Coat type, length, and color

RSPO2 is at 28% for the furnishings allele. The breed does not carry the eyebrows-and-mustache pattern of Wheatens, Schnauzers, or wire-haired terriers.

RSPO2what this gene does

RSPO2 influences the texture and appearance of a dog's coat, particularly the presence of 'furnishings' like mustaches and eyebrows. It helps determine whether a dog has that distinctive wiry or textured look.

For your dog: If your dog has those wiry eyebrows or a mustache, RSPO2 is part of the reason—no health worries, just a coat feature worth knowing about.

Full RSPO2 gene page →

FGF5 sits at 66% for the long-coat variant. Coat length is influenced by other loci as well, so intermediate FGF5 frequencies do not always correspond to intermediate visible coat lengths.

FGF5what this gene does

FGF5 is a gene that influences the length of a dog's coat. It acts like a natural switch, telling hair follicles when to stop growing longer fur.

For your dog: If your dog has a notably long or short coat, FGF5 is likely part of the reason—no action needed, but it’s a neat genetic detail to know.

Full FGF5 gene page →

KRT71 sits at 37% for the wavy/curly variant. Coat curl varies across individuals at this intermediate frequency, and visible expression is also influenced by modifier loci.

KRT71what this gene does

KRT71 is a gene that influences the curliness of a dog's coat. It helps determine whether a dog's fur is straight or has a distinctive curl.

For your dog: If your dog has a curly coat, KRT71 is likely part of the reason; it’s a natural variation, not a health concern.

Full KRT71 gene page →

MC1R sits at 82% at the representative SNP. MC1R controls the switch between red-to-gold pigment and black-to-brown pigment, with the e/e homozygous genotype producing the gold-to-red spectrum. Substrate frequencies at this SNP depend on the array's polarity, so visible coat color in the breed is a more reliable indicator than this single number.

MC1Rwhat this gene does

MC1R is a gene that influences coat color in dogs, affecting how pigments are produced in the fur.

For your dog: Knowing about MC1R gives insight into your dog's coat color but doesn't relate to health issues.

Full MC1R gene page →

Ears

MSRB3 is at 100% for the drop-ear allele, the genetic basis of the breed's signature dropped ear set.

MSRB3what this gene does

MSRB3 is a gene involved in the development of ear shape and structure in dogs.

For your dog: Understanding MSRB3 helps explain why your dog's ears look the way they do, but it isn't linked to any health issues.

Full MSRB3 gene page →

Skull shape

BMP3 sits at 39%, contributing to the breed's moderate, mesaticephalic head shape rather than the extreme brachycephalic form.

BMP3what this gene does

BMP3 is a gene that influences the shape of a dog's skull, particularly contributing to a shorter, broader head shape known as brachycephaly.

For your dog: If your dog has a broad, short skull, it's worth discussing with your vet how this might impact their health, even though BMP3 isn't directly tied to illness.

Full BMP3 gene page →

SMOC2 is at 22%, leaving the breed in the long-headed dolichocephalic form.

SMOC2what this gene does

SMOC2 influences the shape of a dog's skull, particularly affecting how flat or short the face appears.

For your dog: If your dog has a short nose, it's worth discussing with your vet how this trait might impact their health over time.

Full SMOC2 gene page →
Mendelian-disease genetics

What genetic diseases do Boxers carry?

From a panel of 250 Mendelian-disease variants screened in 1,054,293 dogs (Donner et al. 2023), Boxers carry 27 of them at observable frequency. Carrier frequency is not clinical risk. Most recessive variants require two copies for disease expression; many dominant variants show incomplete penetrance. Read this as a population fingerprint of what's in the gene pool, not a per-dog prediction.

Degenerative Myelopathy (DM)
Autosomal recessive (Incomplete penetrance)
high 42.1%
n = 4,552 dogs · 1 variant tested · OMIA:000263-9615 · omia.org →
SOD1what this gene does

SOD1 is a gene that helps protect cells from damage caused by harmful molecules called free radicals.

For your dog: If your dog is a carrier of SOD1 variants, it's worth discussing with your vet, but remember carrier status doesn't mean your dog will get the disease.

Cystinuria Type I-A (SLC3A1 p.I192V)
Autosomal recessive
low 0.48%
n = 4,557 dogs · 3 variants tested · OMIA:000256-9615 · omia.org →
SLC3A1what this gene does

SLC3A1 is a gene that helps transport certain amino acids in the kidneys. It plays a key role in preventing the buildup of cystine, which can form stones.

For your dog: If your dog is from a breed known to carry SLC3A1 variants, it’s worth discussing cystinuria risks with your vet, especially if urinary issues arise.

Hyperuricosuria (HUU)
Autosomal recessive
low 0.30%
n = 4,557 dogs · 1 variant tested · OMIA:001033-9615 · omia.org →
SLC2A9what this gene does

SLC2A9 is a gene that helps regulate uric acid levels in a dog's body. It plays a role in how the kidneys handle this substance.

For your dog: If your dog is one of the breeds known to carry this gene variant, it’s worth discussing with your vet to understand any potential urinary health concerns.

Cystinuria Type I-B (SLC7A9 p.A217T)
Autosomal recessive (Incomplete penetrance)
low 0.27%
n = 4,557 dogs · 2 variants tested · OMIA:001880-9615 · omia.org →
SLC7A9what this gene does

SLC7A9 is a gene that helps transport certain amino acids in the kidneys. It plays a role in how the body handles cystine, an amino acid that can form crystals.

For your dog: If your dog is a carrier, it’s worth discussing with your vet to monitor urinary health and catch any issues early.

Canine Multifocal Retinopathy 1 (Discovered in Mastiff-related breeds; CMR1)
Autosomal recessive
low 0.23%
n = 4,557 dogs · 1 variant tested · OMIA:001444-9615 · omia.org →
BEST1what this gene does

BEST1 is a gene that helps maintain the health of the retina, the light-sensitive layer at the back of the eye. It plays a role in keeping the cells in the retina functioning properly.

For your dog: If your dog is from a breed known to carry BEST1 variants, it’s worth discussing retinal health with your vet, especially if you notice any vision changes.

MDR1 (Multidrug Resistance 1) Medication Sensitivity
Autosomal dominant
low 0.20%
n = 4,557 dogs · 1 variant tested · OMIA:001402-9615 · omia.org →
ABCB1what this gene does

ABCB1 is a gene that helps control how certain drugs are processed and cleared from a dog's body.

For your dog: If your dog is from a breed that carries this gene variant, ask your vet about medication sensitivities before giving any new drugs.

Dilated Cardiomyopathy risk factor (Discovered in the Doberman Pinscher; PDK4-related)
Autosomal dominant (Incomplete penetrance)
low 0.18%
n = 4,557 dogs · 2 variants tested · OMIA:000162-9615 · omia.org →
PDK4what this gene does

PDK4 helps regulate how cells use energy, especially in the heart muscle.

For your dog: If your dog is one of the breeds known to carry this gene, it’s worth discussing heart health with your vet, but being a carrier doesn’t mean your dog will develop disease.

Progressive Rod-Cone Degeneration (prcd-PRA)
Autosomal recessive
low 0.14%
n = 4,548 dogs · 1 variant tested · OMIA:001298-9615 · omia.org →
PRCDwhat this gene does

PRCD is a gene involved in the health of a dog's retina, the part of the eye that detects light and helps with vision.

For your dog: If your dog belongs to a breed known to carry PRCD changes, it's worth discussing eye health and potential genetic testing with your vet.

Chondrodystrophy and Intervertebral Disc Disease Risk (CDDY)
Autosomal dominant
low <0.1%
n = 4,535 dogs · 1 variant tested · OMIA:000157-9615 · omia.org →
FGF4what this gene does

FGF4 influences leg length by affecting bone growth, leading to shorter legs in certain breeds.

For your dog: If your dog is from a breed known to carry this gene, it's worth discussing spinal health with your vet, but being a carrier doesn’t guarantee problems.

Cone-Rod Dystrophy (cord1-PRA/crd4)
Autosomal recessive (Incomplete penetrance)
low <0.1%
n = 4,548 dogs · 1 variant tested · OMIA:001432-9615 · omia.org →
RPGRIP1what this gene does

RPGRIP1 is a gene involved in the function of photoreceptor cells in the eye, which help dogs see in different light conditions.

For your dog: If your dog belongs to a breed known to carry RPGRIP1 mutations, it’s worth discussing with your vet to understand the risks and monitor eye health.

Bleeding disorder (Discovered in the Greater Swiss Mountain Dog; P2RY12-related)
Autosomal recessive
low <0.1%
n = 4,557 dogs · 1 variant tested · OMIA:001564-9615 · omia.org →
P2RY12what this gene does

P2RY12 is a gene that helps control how platelets stick together to form blood clots, which is essential for stopping bleeding.

For your dog: If your dog is from one of these breeds, it’s worth asking your vet about P2RY12 to understand any potential bleeding risks, especially before surgery or injury.

Collie Eye Anomaly (CEA)
Autosomal recessive
low <0.1%
n = 4,557 dogs · 1 variant tested · OMIA:000218-9615 · omia.org →
NHEJ1what this gene does

NHEJ1 is a gene involved in repairing breaks in DNA, helping maintain the integrity of genetic information in cells.

For your dog: If your dog belongs to one of the breeds known to carry this gene variant, it's worth discussing testing with your vet to understand any potential eye health risks.

Protein Losing Nephropathy (PLN; NPHS1-related)
Autosomal recessive (Incomplete penetrance)
low <0.1%
n = 4,557 dogs · 1 variant tested · OMIA:001326-9615 · omia.org →
NPHS1what this gene does

NPHS1 is a gene important for kidney function, helping to keep proteins in the blood where they belong.

For your dog: If your dog’s breed is on the list, it’s worth asking your vet about NPHS1 to understand any risks and keep an eye on kidney health.

Von Willebrand's Disease, Type 1 (vWD 1)
Autosomal recessive
low <0.1%
n = 4,557 dogs · 1 variant tested · OMIA:001057-9615 · omia.org →
Exercise-Induced Collapse (EIC)
Autosomal recessive (Incomplete penetrance)
low <0.1%
n = 4,557 dogs · 1 variant tested · OMIA:001466-9615 · omia.org →
DNM1what this gene does

DNM1 is a gene that helps nerve cells communicate properly by managing how they send signals during muscle activity.

For your dog: If your dog belongs to one of the breeds known to carry this gene variant, it's worth discussing EIC with your vet, especially if your dog is very active or shows signs of weakness during exercise.

Cone-Rod Dystrophy 2 (Discovered in the Pit Bull Terrier; crd2)
Autosomal recessive
low <0.1%
n = 4,557 dogs · 1 variant tested · OMIA:001675-9615 · omia.org →
Cystinuria Type II-A (Discovered in the Australian Cattle Dog)
Autosomal dominant
low <0.1%
n = 4,557 dogs · 1 variant tested · OMIA:001879-9615 · omia.org →
SLC3A1what this gene does

SLC3A1 is a gene that helps transport certain amino acids in the kidneys. It plays a key role in preventing the buildup of cystine, which can form stones.

For your dog: If your dog is from a breed known to carry SLC3A1 variants, it’s worth discussing cystinuria risks with your vet, especially if urinary issues arise.

Neuroaxonal Dystrophy (Discovered in the Rottweiler; VPS11-related)
Autosomal recessive
low <0.1%
n = 4,557 dogs · 1 variant tested · OMIA:002152-9615 · omia.org →
Polyneuropathy with Ocular Abnormalities and Neuronal Vacuolation (Discovered in the Black Russian Terrier and Rottweiler; POANV)
Autosomal recessive
low <0.1%
n = 4,507 dogs · 1 variant tested · OMIA:001970-9615 · omia.org →
RAB3GAP1what this gene does

RAB3GAP1 is a gene involved in nerve cell function, particularly in how cells communicate and maintain their structure.

For your dog: If your dog is one of the breeds known to carry this gene variant, it's worth discussing genetic testing with your vet to understand any potential risks.

Centronuclear Myopathy (Discovered in the Labrador Retriever; HACD1-related; CNM)
Autosomal recessive
low <0.1%
n = 4,556 dogs · 1 variant tested · OMIA:001374-9615 · omia.org →
Plus 7 more at lower frequency. Full table available via the API when shipped.
Source: Donner J et al. 2023. Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics 19(2):e1010651 · Evidence: Limited (DTC ascertainment, tag-SNP proxy) · Confounding MEDIUM · License CC-BY-4.0 · Phene IDs from OMIA (Sydney School of Veterinary Science, The University of Sydney; DOI 10.25910/2AMR-PV70).
Sample size in this breed: 4,557 dogs from the Donner 2023 cohort.

Which Mendelian variants matter most for Boxers?

The Mendelian-disease table above lists 194 variants screened in 4,557 Boxers (Donner 2023). A few stand apart by carrier frequency and clinical impact.

Degenerative Myelopathy (DM)

Degenerative myelopathy in Boxers is a progressive spinal-cord degeneration caused by a variant in SOD1. Affected dogs develop progressive hind-limb weakness, loss of coordination, and eventually paralysis. The disease is incurable and progressive. Age at onset varies; most dogs show signs in later life, though onset timing is not well-characterized in Boxers specifically. 42.1% of Boxers in the Donner cohort carry one copy of the variant (n=4,552). That’s nearly one in two.

The inheritance is autosomal recessive with incomplete penetrance, meaning not every dog with two copies becomes symptomatic. The breed-club Boxer health community focuses on carrier identification and breeding guidance rather than population elimination of the allele. Testing is widely available through commercial DNA labs and breed-club recommended panels.

Cystinuria Type I-A (SLC3A1)

Cystinuria Type I-A in Boxers is an autosomal recessive condition causing excess urinary cystine excretion and bladder-stone formation. Only 0.48% of Boxers in the Donner cohort carry the variant (n=4,557), so homozygous affected dogs are rare. Testing is available if you plan breeding or have a personal history of stones in relatives.

Hyperuricosuria (HUU)

Hyperuricosuria in Boxers is an autosomal recessive disorder of purine metabolism that predisposes to bladder-stone formation. 0.30% of Boxers carry the variant (n=4,557). Penetrance data from Donner show no phenotypically confirmed cases among at-risk dogs in the cohort (0/1), suggesting incomplete or breed-modified expression. Testing exists but is low-priority for most Boxer breeders given the rarity and uncertain penetrance.

How should I test my Boxer?

A breed-specific panel is the high-yield path for breeding stock. The minimum useful set is DM (SOD1) and the cystinuria variants (SLC3A1, SLC7A9) if you have a family history of stones. MDR1 testing is optional but useful if your dog might receive medications like ivermectin or certain chemotherapy agents.

What should I feed a Boxer?

Feeding a Boxer well means feeding around the breed’s brachycephalic physiology and the DM carrier frequency that shapes nearly half the population. Boxers cannot thermoregulate through panting as efficiently as long-muzzled breeds, which means meal timing and exercise windows are tied together in ways that don’t apply to most dogs.

Feed around the heat-of-day. Boxers are prone to exercise-induced hyperthermia. Schedule the main meal in the cool part of the day (morning or evening, not midday), and never exercise hard within two hours of feeding. The breed’s respiratory anatomy makes post-meal exertion riskier than it is for other athletic breeds.

Joint and neuromuscular health matter. The 42.1% DM carrier frequency (Donner 2023, n=4,552) and the breed’s athletic build make controlled exercise and stable joint support important. A large-breed adult formula with glucosamine and chondroitin is a reasonable addition after age four, though peer-reviewed evidence on supplement efficacy in asymptomatic carriers is sparse. Weight management is higher-yield. Weight management is the most consistently recommended modifiable factor for dogs at risk of DM.

Cardiac monitoring is breed-routine. Boxers have a breed-recognized risk of cardiac arrhythmia and structural disease (American Boxer Club health guidelines; OFA cardiac registry). Annual veterinary exams with auscultation are standard. Dietary supplementation with taurine is reasonable though not proven to prevent disease in this breed; most commercial large-breed formulas include adequate taurine (NRC 2006 minimum: 1.0g/1000kcal for adults).

What we don’t know

We do not yet know which Boxers in that 42.1% DM carrier pool become symptomatic and which remain clinically silent. Penetrance is incomplete, but the genetic and environmental factors that tip a carrier into disease are largely uncharted. Age at onset varies widely even among phenotypically confirmed cases.

Environmental and dietary modifiers of DM progression are understudied in Boxers specifically. The honest summary is that published analyses have returned few actionable prevention strategies beyond weight management and avoiding overexertion in middle-aged carriers.

Boxer cardiac disease is a known health concern in the breed. A TTN variant associated with dilated cardiomyopathy risk is present in the population at low frequency (0.18%, Donner 2023), and broader rhythm-disorder screening protocols are not yet standardized across breed-club organizations. Rhythm disorders can be silent until they cause collapse or sudden death.

Frequently asked questions about Boxers

Are Boxers prone to degenerative myelopathy? Yes. 42.1% of Boxers carry one copy of the DM variant (Donner 2023, n=4,552). Dogs need two copies to be at risk, but the high carrier frequency means breeders and owners should be aware. Not all at-risk dogs become symptomatic.

What is the median lifespan of a Boxer? The atlas-derived median is 10.2 years. Individual dogs vary widely, and proper screening, feeding, and weight management during the middle years (ages 4-10) matter most.

Should I do a DNA test on my Boxer? For breeding stock, yes. The DM test is the highest-yield panel, especially given the 42.1% carrier frequency in the breed. If your Boxer might receive medications like ivermectin or chemotherapy, MDR1 testing is also useful.

What is the most common genetic disease in Boxers? Degenerative myelopathy. It is the highest-frequency variant in the breed and the most consequential for breeding decisions and long-term care planning.

Are Boxers good with children? Boxers are energetic and affectionate with family. They were bred as working dogs and retain a strong drive for interaction. Proper socialization and exercise management are essential, especially given the breed’s strength and exuberance.

Can I exercise my Boxer in hot weather? With caution. Boxers have brachycephalic (short-muzzled) anatomy that limits their ability to cool through panting. Avoid strenuous exercise during the heat of the day. Early morning or evening exercise is safer.

What should I feed a Boxer puppy? A large-breed puppy formula with controlled calcium (0.8-1.2% on a dry-matter basis) and a calcium-to-phosphorus ratio between 1.1:1 and 2:1 (NRC 2006). Avoid overfeeding to prevent too-rapid growth, which stresses developing joints.

Is my Boxer at risk for heart disease? Cardiac arrhythmia and structural disease occur in Boxers. Annual veterinary cardiac auscultation is standard. Discuss any symptoms (lethargy, collapse, coughing) with your vet. Screening protocols vary; consult your breed-club health guidelines.

A gift to human medicine

Boxers are a natural model for human disease

Because the same genes cause the same conditions across species, the inherited conditions documented in Boxers help researchers understand, and work toward treating, the human diseases they model. This is the dog advancing human medicine. The breed models the human disease; it does not have it, and this is not a prediction for your dog.

Human equivalents via OMIA → Mondo / OMIM. Model-of, not identity.
Documented in OMIA

Every condition recorded in the Boxer

Beyond the testable carriers above, OMIA's literature catalogue records 23 genetic conditions in the Boxer, 15 of which have a known human equivalent. This is the documented landscape across all Boxers ever studied, not a prediction for any one dog.

Plus 5 more conditions recorded in the Boxer in OMIA.

Online Mendelian Inheritance in Animals (OMIA); Nicholas, Tammen & Sydney Informatics Hub, DOI 10.25910/2AMR-PV70
Documented in the breed's literature is not carrier status and not a forecast for an individual dog. Human equivalents are mapped via Mondo/OMIM. Carrier frequencies (above) are the separately-measured testable subset (Donner 2023).
The data behind this page

Where every number on this page came from.

This page draws on three primary data sources. Carrier frequencies for the Mendelian section come from Donner et al. 2023 (CC-BY-4.0). We grade these data at evidence Limited because the cohort is a direct-to-consumer ascertainment, which biases toward owners who chose to test their dogs. The panel also uses tag-SNP proxies for some variants rather than direct causal-variant assays. Limited is a study-design grade, not a quality grade: the Donner cohort is the largest open canine-genotype dataset in existence and we are grateful for it. We rate the confounding MEDIUM.

Population-genetic dimensions (heterozygosity, intra-breed PCA distance, nearest neighbors, trait-locus frequencies) come from CanVAS (Brundage 2026), harmonized through the Sniff Atlas. The exact release date and verification commit are pinned at the bottom of the page so a researcher can trace a number back to a specific snapshot. The disease-gene-variant graph comes from OMIA (Online Mendelian Inheritance in Animals; Nicholas, Tammen, and the Sydney Informatics Hub at the Sydney School of Veterinary Science, The University of Sydney; retrieved April 2026, DOI 10.25910/2AMR-PV70).

What this page does not yet have. Inheritance modes and per-disease penetrance evidence from Donner 2023 are now in the structured data for every variant the panel covers. Mondo, OMIM, Ensembl, and HGNC cross-references on gene pages remain pending, they arrive in December 2026 alongside the imputed 9.67M-variant CanVAS dataset via the OMIA SQL dump absorption. Until then, gene IDs carry NCBI Gene and OMIA phene URLs only; the wider human-homolog and disease-ontology cross-reference set fills in with that release.

How to cite this page. The computed dimensions on this page are derived from the open Sniff Atlas v1.0.1 (Gehring 2026, doi:10.5281/zenodo.20566358, CC-BY 4.0). Full citation formats including BibTeX, RIS, and CITATION.cff at sniff.world/cite.

Add your boxer to the atlas

We have 192 boxers. We do not have yours.

Every boxer added sharpens the breed's genetic neighborhood. Enrollment is free. The data stays open. The star is permanent.

Add your boxer now as a Charted star
Want to wait for DNA uploads?

Leave your email and we'll let you know the moment DNA uploads open for Boxers.

References
  1. Donner J, Freyer J, Davison S, Anderson H, Blades M, Honkanen L, et al. (2023). Genetic prevalence and clinical relevance of canine Mendelian disease variants in over one million dogs. PLOS Genetics 19(2):e1010651. doi:10.1371/journal.pgen.1010651
  2. Brundage J, et al. (2026). CanVAS: a harmonized canine variant atlas. bioRxiv. doi:10.64898/2026.04.13.718238
  3. Nicholas, F.W., Tammen, I., & Sydney Informatics Hub. (2026). Online Mendelian Inheritance in Animals (OMIA) [dataset]. The University of Sydney. https://omia.org. doi:10.25910/2AMR-PV70 (retrieved April 2026).
Last updated
Sources: CanVAS (Brundage 2026) · Donner 2023 · OMIA